Blood Product Utilization with Left Ventricular Assist Device Implantation: A Decade of Statewide Data
- 1 May 2016
- journal article
- adult circulatory-support
- Published by Ovid Technologies (Wolters Kluwer Health) in ASAIO Journal
- Vol. 62 (3), 268-273
- https://doi.org/10.1097/mat.0000000000000345
Abstract
Blood transfusion rates with cardiac surgery over time have decreased, this trend has not been examined for patients undergoing left ventricular assist device (LVAD) implantation. We investigated blood transfusion trends with LVAD implantation in a statewide database. Between July 2004 and June 2014, 666 LVADs were implanted (age 54.5 ± 12.6 years. 77% men). Reoperation for bleeding was required in 22% of cases. Postoperative mortality was 13.2%. Over the decade, use of any blood products with LVAD surgery by year ranged from 83% to 100% (92 ± 5.3%). Intraoperative and postoperative blood products use was 71.8% and 73%, respectively. Only 7.4% of patients did not receive any blood products. Blood transfusion during surgery consisted of plasma (60%), platelets (56%), red blood cells (RBCs) (44.3%), and cryoprecipitate (32%), whereas after surgery RBC use was more frequent (68%). Compared with the initial 5 years (2005–2009), the units of blood transfused in the second 5 years (2010–2014) were significantly less, 21 ± 23 units vs. 16.6 ± 20.5 units, p = 0.0038. By multivariable analysis, preoperative factors predictive of blood transfusion are lower hematocrit, lower BMI, reoperative surgery, requirement for intraaortic balloon pump (IABP), and nonelective surgery. Blood transfusion with LVAD implantation remains very high. However, the amount of blood product transfused has decreased in the last 5 years.Keywords
This publication has 27 references indexed in Scilit:
- Perioperative Blood Product Use: A Comparison Between HeartWare and HeartMate II DevicesThe Annals of Thoracic Surgery, 2014
- Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2013
- 2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice GuidelinesThe Annals of Thoracic Surgery, 2011
- Bleeding Complications and Blood Product Utilization With Left Ventricular Assist Device ImplantationThe Annals of Thoracic Surgery, 2011
- Hospital variation in transfusion and infection after cardiac surgery: a cohort studyBMC Medicine, 2009
- Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac SurgeryCirculation, 2007
- Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting*Critical Care Medicine, 2006
- Allosensitization in heart transplantation: implications and management strategiesCurrent Opinion in Cardiology, 2003
- Effect of blood transfusion on long-term survival after cardiac operationThe Annals of Thoracic Surgery, 2002
- Transfusion of Blood Components and Postoperative Infection in Patients Undergoing Cardiac SurgerySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2001